Early-Life Antibiotics Alter Infant Gut Microbiome
Major shift seen in composition and in antimicrobial resistance gene profile directly after treatment, which normalized over 12 months
Survival High With ECMO for Selected Severe COVID-19 Patients
Of 30 patients, 90 percent survived to discharge; survival was 86.7 percent at median follow-up of 10.8 months since ECMO cannulation
Nonantibiotic Prophylaxis Noninferior for Recurrent UTI
Incidence of antibiotic-treated UTI during 12-month treatment period noninferior for methenamine hippurate versus prophylactic antibiotics
Interim Estimate Suggests Flu Shot Not Effective in 2021-2022 Season
Vaccine effectiveness against medically attended outpatient acute respiratory infection associated with A(H3N2) was 16 percent
U.S. Airplane, Train, and Transit Mask Mandates Extended to April 18
Extension comes at the recommendation of the U.S. Centers for Disease Control and Prevention
Continued Dexamethasone at Discharge Not Tied to Better COVID-19 Outcomes
No association seen with reduced 14-day all-cause readmission or mortality for individuals continuing dexamethasone at discharge
Exhaustion-Related Burnout Higher in Underrepresented Medical Students
However, medical students who are underrepresented in medicine less likely to report disengagement
Excess Mortality Seen for Seniors With Alzheimer Disease, Dementia in COVID-19
Enrollees with ADRD had increased adjusted mortality, especially for Asian, Black, Hispanic populations with ADRD
COVID-19 Vaccination Coverage Higher in Urban Versus Rural Counties
Completion of primary series was higher in urban than rural counties; receipt of booster similarly low in both urban, rural counties
In Reversal, WHO Now Supports COVID-19 Boosters
Number of studies show that booster doses help restore weakening immunity and protect against severe COVID-19
